Eupatilin induces human renal cancer cell apoptosis via ROS‑mediated MAPK and PI3K/AKT signaling pathways

  • Authors:
    • Wei‑Feng Zhong
    • Xiao‑Hong Wang
    • Bin Pan
    • Feng Li
    • Lu Kuang
    • Ze‑Xuan Su
  • View Affiliations

  • Published online on: August 10, 2016     https://doi.org/10.3892/ol.2016.4989
  • Pages: 2894-2899
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Phosphatidylinositol 3-kinase (PI3K)/AKT and mitogen activated protein kinase (MAPK) signaling cascades have significant roles in cell proliferation, survival, angiogenesis and metastasis of tumor cells. Eupatilin, one of the major compounds present in Artemisia species, has been demonstrated to have antitumor properties. However, the effect of eupatilin in renal cell carcinoma (RCC) remains to be elucidated. Therefore, the present study investigated the biological effects and mechanisms of eupatilin in RCC cell apoptosis. The results of the present study demonstrated that eupatilin significantly induced cell apoptosis and enhanced the production of reactive oxygen species (ROS) in 786‑O cells. In addition, eupatilin induced phosphorylation of p38α (Thr180/Tyr182), extracellular signal‑regulated kinase 1/2 and c‑Jun N‑terminal kinase 1/2 (Thr183/Tyr185), and decreased the phosphorylation of PI3K and AKT in 786‑O cells in a concentration‑dependent manner. Furthermore, the ROS inhibitor N‑acetyl‑L‑cysteine was able to rescue the MAPK activation and PI3K/AKT inhibition induced by eupatilin. Taken together, the results of the present study provide evidence that inhibition of eupatilin induces apoptosis in human RCC via ROS‑mediated activation of the MAPK signaling pathway and inhibition of the PI3K/AKT signaling pathway. Thus, eupatilin may serve as a potential therapeutic agent for the treatment of human RCC.
View Figures
View References

Related Articles

Journal Cover

October-2016
Volume 12 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhong WF, Wang XH, Pan B, Li F, Kuang L and Su ZX: Eupatilin induces human renal cancer cell apoptosis via ROS‑mediated MAPK and PI3K/AKT signaling pathways. Oncol Lett 12: 2894-2899, 2016
APA
Zhong, W., Wang, X., Pan, B., Li, F., Kuang, L., & Su, Z. (2016). Eupatilin induces human renal cancer cell apoptosis via ROS‑mediated MAPK and PI3K/AKT signaling pathways. Oncology Letters, 12, 2894-2899. https://doi.org/10.3892/ol.2016.4989
MLA
Zhong, W., Wang, X., Pan, B., Li, F., Kuang, L., Su, Z."Eupatilin induces human renal cancer cell apoptosis via ROS‑mediated MAPK and PI3K/AKT signaling pathways". Oncology Letters 12.4 (2016): 2894-2899.
Chicago
Zhong, W., Wang, X., Pan, B., Li, F., Kuang, L., Su, Z."Eupatilin induces human renal cancer cell apoptosis via ROS‑mediated MAPK and PI3K/AKT signaling pathways". Oncology Letters 12, no. 4 (2016): 2894-2899. https://doi.org/10.3892/ol.2016.4989